Neurobehavioral differences in value-based decision making between people with cocaine use disorder and controls.
Experimental and Clinical Psychopharmacology · 2026
DOI: 10.1037/pha0000840 ↗At a glance
Journal article in Experimental and Clinical Psychopharmacology, 2026. Written by Joshua A Lile and 6 co-authors. Institution: Department of Behavioral Science, University of Kentucky, College of Medicine. Major MEDLINE topics: Cocaine-Related Disorders, Decision Making. The full text is freely available in PubMed Central. Funded by: NIDA NIH HHS, National Institutes of Health; National Institute on Drug Abuse, NCATS NIH HHS.
Abstract (original language)
Decision making occurs in dynamic contexts in which the individual and reward attributes change, requiring that predicted reward values of options be updated continually and applied to future choices to maximize reward. Value processing relies on corticostriatal dopamine, which is dysregulated in people with cocaine use disorder (pwCocUD), but whether these individuals differ in value-based decision making has only recently been considered. A probabilistic concurrent monetary choice task with reversals, reinforcement learning modeling, and functional magnetic resonance imaging were used to assess value-based decision making in nontreatment-seeking pwCocUD and matched controls (n = 17 [8F and 9M] per group; n = 34 total). Both groups were sensitive to reinforcement probabilities, but pwCocUD made significantly fewer choices for the high probability reward option. Reinforcement learning modeling revealed that pwCocUD had lower β parameter estimates, indicating reduced consistency in using relative option values to make choices. Significant correlations between the application of value (i.e., β parameter) and value-modulated activity during choice deliberation were identified in brain regions previously linked to reinforcement learning and exploiting versus exploring choice options in both groups. A significant group difference in the strength of this relationship was found in medial frontal control regions, including the dorsal anterior cingulate cortex, which has been associated with the explore-exploit trade-off, suggesting that the differential engagement of these areas contributed to group differences in choice behavior. This research contributes to our understanding of suboptimal decisions made by pwCocUD in uncertain, low-reward contexts and support targeting networks involved in value-based decision making for neuromodulation intervention development. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Behavioral Science, University of Kentucky, College of Medicine.
- Department of Biostatistics, University of Kentucky, College of Public Health.
- Department of Psychiatry, University of Maryland School of Medicine.
- Department of Psychology, University of Kentucky, College of Arts and Sciences.
ORCID profiles: Joshua A Lile, Preston T Tolbert
Funding
- NIDA NIH HHS
- National Institutes of Health; National Institute on Drug Abuse
- NCATS NIH HHS
- National Institutes of Health
Cite
APA
Lile, J. A., Tolbert, P. T., Shellenberg, T. P., Stoops, W. W., Strickland, J. C., Beckmann, J. S., & Wesley, M. J. (2026). Neurobehavioral differences in value-based decision making between people with cocaine use disorder and controls. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000840
Vancouver
Lile JA, Tolbert PT, Shellenberg TP, Stoops WW, Strickland JC, Beckmann JS, et al. Neurobehavioral differences in value-based decision making between people with cocaine use disorder and controls. Experimental and Clinical Psychopharmacology. 2026. doi:10.1037/pha0000840
BibTeX
@article{Lile2026,
author = {Lile, Joshua A and Tolbert, Preston T and Shellenberg, Thomas P and Stoops, William W and Strickland, Justin C and Beckmann, Joshua S and Wesley, Michael J},
title = {Neurobehavioral differences in value-based decision making between people with cocaine use disorder and controls},
journal = {Experimental and Clinical Psychopharmacology},
year = {2026},
doi = {10.1037/pha0000840}
}
EUVIMED